Regeneron Pharmaceuticals (REGN) total assets

Total assets · fiscal 2025
$40.56B

Regeneron Pharmaceuticals (REGN) had total assets of $40.56B at the end of fiscal 2025 (December 31, 2025). That is 7.4% higher than the $37.76B of fiscal 2024. Figures as of 18 Nov 2026, 10:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$40.56B
Change on fiscal 2024
+7.4%
Growth, 5 years
+18.8% a year
Growth, 10 years
+21.9% a year
Highest on record
$40.56Bfiscal 2025
Lowest on record
$741.20Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Regeneron Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 18.8% a year; over ten years the rate was 21.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $40.56B in fiscal 2025 and the lowest $741.20M in fiscal 2009.

History · 17 fiscal years

Total assets by fiscal year

Regeneron Pharmaceuticals total assets, year by year

Regeneron Pharmaceuticals (REGN) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$40.56B 7.4% up
2024$37.76B 14.1% up
2023$33.08B 13.2% up
2022$29.21B 14.9% up
2021$25.43B 48.2% up
2020$17.16B 15.9% up
2019$14.81B 26.2% up
2018$11.73B 33.9% up
2017$8.76B 25.7% up
2016$6.97B 24.3% up
2015$5.61B 46.2% up
2014$3.84B 30.0% up
2013$2.95B 41.8% up
2012$2.08B 57.2% up
2011$1.32B 21.5% up
2010$1.09B 47.0% up
2009$741.20M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Regeneron Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
GSK GSK£61.12B2025
Regeneron Pharmaceuticals REGN$40.56B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on REGN

Regeneron Pharmaceuticals, figure by figure

Regeneron Pharmaceuticals (REGN) overview: price, valuation and scorecardAll health care companies by market value

Regeneron Pharmaceuticals total assets: questions and answers

How large are Regeneron Pharmaceuticals's total assets?

Regeneron Pharmaceuticals (REGN) had total assets of $40.56B at the end of fiscal 2025 (December 31, 2025). That is 7.4% higher than the $37.76B of fiscal 2024.

What is the growth rate of Regeneron Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 18.8% a year; over ten years the rate was 21.9% a year.

What are the highest and lowest total assets figures on record for Regeneron Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $40.56B in fiscal 2025 and the lowest $741.20M in fiscal 2009.

How is Regeneron Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Regeneron Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regeneron Pharmaceuticals (REGN) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/REGN/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.